Gemfibrozil
21 NDCs across 10 manufacturers|21 Generic,0 Brand
Gemfibrozil is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 25, 1993. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $14 million on Gemfibrozil across 754,000 claims for 186,000 beneficiaries.
Gemfibrozil is available as 21 NDCs from 10 manufacturers (21 generic, 0 brand), with NADAC prices from $0.09 to $0.11 per EA — a 24% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
21
21G / 0B
Manufacturers
10
competing in market
Price Spread
$0.09 – $0.11
per EA
7d Activity
avg -0.7% WoW · of 21 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
NorthStar Rx LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing GEMFIBROZIL(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GEMFIBROZIL 600 MG TABLET | $0.1104 per EA | — |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1038 per EA | -0.73% |
GEMFIBROZIL 600 MG TABLET | $0.1030 per EA | — |
GEMFIBROZIL 600 MG TABLET | $0.0891 per EA | — |
Frequently Asked Questions
What is Gemfibrozil used to treat?
Gemfibrozil is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
When did Gemfibrozil become available as a generic?
FDA approved the first generic Gemfibrozil (ANDA) on Jan 25, 1993. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Gemfibrozil?
In 2024, Medicare Part D spent $14 million on Gemfibrozil across 754,000 claims for 186,000 beneficiaries.
How many Gemfibrozil products are on the market?
The Gemfibrozil drug market contains 21 NDCs from 10 manufacturers — 21 generic and 0 brand products.
What is the price range for Gemfibrozil?
NADAC reference prices for Gemfibrozil range from $0.0891 to $0.1104 per EA — a 24% difference between cheapest and most expensive.
Which manufacturers make Gemfibrozil?
10 manufacturers list Gemfibrozil in NADAC. Ranked by number of NDCs, the largest are NorthStar Rx LLC (4), Nivagen Pharmaceuticals Inc. (3), Exelan Pharmaceuticals Inc. (3), Rising Pharma Holdings Inc. (2), Camber Pharmaceuticals Inc. (2).
How has the price of Gemfibrozil changed recently?
Over the past 7 days, 0 Gemfibrozil NDCs rose and 18 fell, with a market-wide average change of -0.7%.